| pubmed-article:16535964 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16535964 | lifeskim:mentions | umls-concept:C0015385 | lld:lifeskim |
| pubmed-article:16535964 | lifeskim:mentions | umls-concept:C0022661 | lld:lifeskim |
| pubmed-article:16535964 | lifeskim:mentions | umls-concept:C0022116 | lld:lifeskim |
| pubmed-article:16535964 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:16535964 | lifeskim:mentions | umls-concept:C0581603 | lld:lifeskim |
| pubmed-article:16535964 | lifeskim:mentions | umls-concept:C1511545 | lld:lifeskim |
| pubmed-article:16535964 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:16535964 | pubmed:dateCreated | 2006-3-15 | lld:pubmed |
| pubmed-article:16535964 | pubmed:abstractText | End stage renal disease [ESRD] and diabetes have a negative effect on outcome of arterial reconstructions, because they are associated with a vulnerability to infection, an infrageniculate arterial occlusive disease and an increased perioperative risk. The combination of both in critically ischemic patients is traditionally considered a great threat to their limb or life. The risk/benefit ratio of revascularization in this clinical setting is marginal and therefore the decision making is controversial. This study was undertaken to determine the results of arterial reconstruction in patients with end-stage renal disease and diabetes mellitus. | lld:pubmed |
| pubmed-article:16535964 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16535964 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16535964 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16535964 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16535964 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:16535964 | pubmed:issn | 0301-1526 | lld:pubmed |
| pubmed-article:16535964 | pubmed:author | pubmed-author:BramisJJ | lld:pubmed |
| pubmed-article:16535964 | pubmed:author | pubmed-author:HeppWW | lld:pubmed |
| pubmed-article:16535964 | pubmed:author | pubmed-author:LangerSS | lld:pubmed |
| pubmed-article:16535964 | pubmed:author | pubmed-author:BaunachCC | lld:pubmed |
| pubmed-article:16535964 | pubmed:author | pubmed-author:BastounisEE | lld:pubmed |
| pubmed-article:16535964 | pubmed:author | pubmed-author:GeorgopoulouU... | lld:pubmed |
| pubmed-article:16535964 | pubmed:author | pubmed-author:PapalambrosEE | lld:pubmed |
| pubmed-article:16535964 | pubmed:author | pubmed-author:SigalaFF | lld:pubmed |
| pubmed-article:16535964 | pubmed:author | pubmed-author:BakoyiannisCC | lld:pubmed |
| pubmed-article:16535964 | pubmed:author | pubmed-author:SigalasKK | lld:pubmed |
| pubmed-article:16535964 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16535964 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:16535964 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16535964 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16535964 | pubmed:pagination | 15-20 | lld:pubmed |
| pubmed-article:16535964 | pubmed:dateRevised | 2008-2-13 | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:meshHeading | pubmed-meshheading:16535964... | lld:pubmed |
| pubmed-article:16535964 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16535964 | pubmed:articleTitle | Outcome of infrainguinal revascularization for critical limb ischemia in diabetics with end stage renal disease. | lld:pubmed |
| pubmed-article:16535964 | pubmed:affiliation | Kplus Vascular Centre Haan, Department of Vascular and Endovascular Surgery, St. Josef Hospital Haan GmbH, Haan, Germany. drfsigala@yahoo.gr | lld:pubmed |
| pubmed-article:16535964 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16535964 | lld:pubmed |
